|
You must be logged in to view the content from the NCCN Drugs & Biologics Compendium®. Login or Register now!
|
|
|
NCCN Acute Myeloid Leukemia Panel
|
NCCN Guidelines for Acute Myeloid Leukemia
|
|
|
NCCN Colon/Rectal/Anal Cancers Panel
|
NCCN Guidelines for Anal Carcinoma |
- Bladder Cancer
- Bladder Cancer
- Upper GU Tract Tumors
- Urothelial Carcinoma of the Prostate
|
NCCN Bladder Cancer Panel
|
NCCN Guidelines for Bladder Cancer |
- Bone Cancer
- Ewing's Sarcoma
- Osteosarcoma
|
NCCN Bone Cancer Panel
|
NCCN Guidelines for Bone Cancer |
- Breast Cancer
-
Breast Cancer, Noninvasive
-
Breast Cancer, Invasive
-
Paget’s Disease
-
Breast Cancer During Pregnancy
|
NCCN Breast Cancer Panel
|
NCCN Guidelines for Breast Cancer |
- Central Nervous System Cancers
- Adult Low-Grade Infiltrative Supratentorial Astrocytoma/
Oligodendroglioma (excluding pilocytic astrocytoma)
- Anaplastic Gliomas/Glioblastoma
- Adult Intracranial Ependymoma
- Adult Medulloblastoma and Supratentorial PNET
- Primary CNS Lymphoma
- Meningiomas
- Limited (1-3) Metastatic Lesions
- Multiple (>3) Metastatic Lesions
- Leptomeningeal Metastases
- Metastatic Spine Tumors
|
NCCN Central Nervous System Cancers Panel
|
NCCN Guidelines for Central Nervous System Cancers |
|
|
NCCN Cervical/Uterine Cancers Panel
|
NCCN Guidelines for Cervical Cancer |
- Chronic Myelogenous Leukemia
|
NCCN Chronic Myelogenous Leukemia Panel
|
NCCN Guidelines for Chronic Myelogenous Leukemia |
|
|
NCCN Colon/Rectal/Anal Cancers Panel
|
NCCN Guidelines for Colon Cancer |
- Esophageal and Esophagogastric Junction Cancers
|
NCCN Esophageal/Gastric Cancers Panel
|
NCCN Guidelines for Esophageal Cancer |
|
|
NCCN Esophageal/Gastric Cancers Panel
|
NCCN Guidelines for Gastric Cancer |
- Head and Neck Cancers
- Cancer of the Lip
- Cancer of the Oral Cavity
- Cancer of the Oropharynx
- Cancer of the Hypopharynx
- Cancer of the Nasopharynx
- Cancer of the Glottic Larynx
- Cancer of the Supraglottic Larynx
- Ethmoid Sinus Tumors
- Maxillary Sinus Tumors
- Unresectable and Recurrent Head and
Neck Cancers
- Occult Primary
|
NCCN Head and Neck Cancers Panel
|
NCCN Guidelines for Head and Neck Cancers |
- Hepatobiliary Cancers
- Hepatocellular Carcinoma
- Gallbladder Cancer
- Intrahepatic Cholangiocarcinoma
- Extrahepatic Cholangiocarcinoma
|
NCCN Hepatobiliary Cancers Panel
|
NCCN Guidelines for Hepatobiliary Cancers |
- Hodgkin Lymphoma
- Classical Hodgkin Lymphoma
- Lymphocyte-predominant Hodgkin Lymphoma
|
NCCN Hodgkin Lymphoma Panel
|
NCCN Guidelines for Hodgkin Lymphoma |
|
|
NCCN Kidney/Testicular Cancers Panel
|
NCCN Guidelines for Kidney Cancer |
- Malignant Pleural Mesothelioma
|
NCCN Non-Small Cell Lung Cancer Panel
|
NCCN Guidelines for Malignant Pleural Mesothelioma |
|
|
NCCN Melanoma Panel
|
NCCN Guidelines for Melanoma |
- Multiple Myeloma/Other Plasma Cell Neoplasms
|
NCCN Multiple Myeloma Panel
|
|
|
|
|
NCCN Guidelines for Multiple Myeloma
|
- Systemic Light Chain Amyloidosis
|
|
NCCN Guidelines for Systemic Light Chain Amyloidosis
|
- Waldenström's Macroglobulinemia/
Lymphoplasmacytic Lymphoma
|
|
NCCN Guidelines for Waldenström's Macroglobulinemia/ Lymphoplasmacytic Lymphoma
|
- Myelodysplastic Syndromes
|
NCCN Myelodysplastic Syndromes Panel
|
NCCN Guidelines for Myelodysplastic Syndromes |
- Neuroendocrine Tumors
- Carcinoid Tumors
- Pancreatic Endocrine Tumors (Islet Cell Tumors)
- Adrenal Gland Tumors
- Pheochromocytoma
- Poorly Differentiated (High Grade or Anaplastic)/Small Cell
- Multiple Endocrine Neoplasia Type 1
|
NCCN Neuroendocrine Tumors Panel
|
NCCN Guidelines for Neuroendocrine Tumors |
- Non-Hodgkin's Lymphomas
- Chronic Lymphocytic Leukemia/
Small Lymphocytic Lymphoma
- Follicular Lymphoma
- Marginal Zone Lymphoma
- Gastric MALT Lymphoma
- Nongastric MALT Lymphoma
- Splenic Marginal Zone Lymphoma
- Mantle Cell Lymphoma
- Diffuse Large B-Cell Lymphoma
- Burkitt's Lymphoma
- Lymphoblastic Lymphoma
- AIDS-Related B-Cell Lymphoma
- Peripheral T-Cell Lymphoma
- Mycosis Fungoides and Sezary Syndrome
- Primary Cutaneous B-Cell Lymphoma
- Adult T-Cell Leukemia/Lymphoma
|
NCCN Non-Hodgkin`s Lymphomas Panel
|
NCCN Guidelines for Non-Hodgkin's Lymphomas |
- Non-Melanoma Skin Cancers
|
NCCN Non-Melanoma Skin Cancer Panel
|
|
- Basal and Squamous Cell Skin Cancers
|
|
NCCN Guidelines for Basal and Squamous Cell Skin Cancers |
- Dermatofibrosarcoma Protuberance (DFSP)
|
|
NCCN Guidelines for Dermatofibrosarcoma Protuberance (DFSP) |
|
|
|
NCCN Guidelines for Merkel Cell Carcinoma |
- Non-Small Cell Lung Cancer
|
NCCN Non-Small Cell Lung Cancer Panel
|
NCCN Guidelines for Non-Small Cell Lung Cancer |
|
|
NCCN Occult Primary Panel
|
NCCN Guidelines for Occult Primary |
- Ovarian Cancer
- Epithelial Ovarian Cancer/Fallopian Tube Cancer/
Primary Peritoneal Cancer
- Germ Cell
- Ovarian Stromal
|
NCCN Ovarian Cancer Panel
|
NCCN Guidelines for Ovarian Cancer |
- Pancreatic Adenocarcinoma
|
NCCN Pancreatic Adenocarcinoma Panel
|
NCCN Guidelines for Pancreatic Adenocarcinoma |
|
|
NCCN Prostate Cancer Panel
|
NCCN Guidelines for Prostate Cancer |
|
|
NCCN Colon/Rectal/Anal Cancers Panel
|
NCCN Guidelines for Rectal Cancer |
- Small Cell Lung Cancer
- Small Cell Lung Cancer
- Lung Neuroendocrine Tumors
|
NCCN Small Cell Lung Cancer Panel
|
NCCN Guidelines for Small Cell Lung Cancer |
- Soft Tissue Sarcoma
- Soft Tissue Sarcoma of the Extremity/Trunk
- Retroperitoneal/Intra-abdominal
- Angiosarcoma
- Gastrointestinal Stromal Tumors (GIST)
- Desmoid Tumors (Fibromatosis)
- Solitary Fibrous Tumor/Hemangiopericytoma
- Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor
- Alveolar Soft Part Sarcoma
- PEComa/Recurrent Angiomyolipoma/Lymphangioleiomyomatosis
- Chordoma
|
NCCN Soft Tissue Sarcoma Panel
|
NCCN Guidelines for Soft Tissue Sarcoma |
|
|
NCCN Kidney/Testicular Cancers Panel
|
NCCN Guidelines for Testicular Cancer |
- Thymomas and Thymic Carcinomas
|
NCCN Non-Small Cell Lung Cancer Panel
|
NCCN Guidelines for Thymomas and Thymic Carcinomas |
- Thyroid Carcinoma
- Papillary Carcinoma
- Follicular Carcinoma
- Hürthle Carcinoma
- Medullary Carcinoma
|
NCCN Thyroid Carcinoma Panel
|
NCCN Guidelines for Thyroid Carcinoma |
- Uterine Neoplasms
- Endometrial Carcinoma
- Uterine Sarcoma
|
NCCN Cervical/Uterine Cancers Panel
|
NCCN Guidelines for Uterine Neoplasms |